✦ LIBER ✦

HIV-1 antibody positive hepatitis B surface antigen serum in a dental school patient population

✍ Scribed by James E. Cade; Charles H. Boozer; Diana M. Lancaster; Gwendolyn Lundgren

Book ID: 113199092
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 816 KB
Volume: 78
Category: Article
ISSN: 0030-4220
DOI: 10.1016/0030-4220(94)90183-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PREVALENCE OF HEPATITIS B SURFACE ANTIGE

PREVALENCE OF HEPATITIS B SURFACE ANTIGEN IN A DENTAL SCHOOL PATIENT POPULATION

✍ Michael J. Tullman; Ronald A. Barrett; Charles H. Boozer; J. T. Hamrick; Jack H. 📂 Article 📅 1978 🏛 American Association of Public Health Dentistry 🌐 English ⚖ 349 KB

The incidence and prevalence of hepatiti

The incidence and prevalence of hepatitis B surface antibody in a dental school population

✍ Patrick K. Hardman; Ronald E. Gier; Gary Tegtmeier 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 404 KB

Absence of hepatitis B virus DNA detecte

Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers

✍ D.D. Douglas; H.F. Taswell; J. Rakela; D. Rabe 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 475 KB

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-α1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody—and hepatitis B virus DNA—positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

ment for anti-HBe-positive chronic hepatitis. The benefit It has recently been shown that thymosin-a 1 (T-a 1 ), a of this agent in producing long-term inhibition of HBV synthetic polypeptide of thymic origin, is able to proreplication must be confirmed by future trials. (HEPAmote disease remission

A randomized controlled trial of thymosi

A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody-and hepatitis B virus DNA-positive chronic hepatitis B

✍ P Andreone; C Cursaro; A Gramenzi; C Zavaglia; I Rezakovic; E Altomare; R Severi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB